REQUEST A DEMO
Total
USD $0.00
« Back to previous page

Thailand Pharma and Healthcare Sector Report 2025-2026

An EMIS Insights Industry Report
EMIS is an ISI Markets Company
Date: May 2025
Pages: 42
Available in: English

Thailand's pharmaceutical and healthcare industries have grown significantly in recent decades. In 2002, the Thai government began providing universal healthcare to all Thai citizens, a successful initiative covering more than 99.9% of the Thai population. Thailand is also a well-known global medical hub, with more Joint Commission International-accredited hospitals than any other ASEAN country. Despite these notable achievements, Thailand still has significant gaps in healthcare coverage. The healthcare system is overly focused on curative care, which, when combined with Thailand's rapidly ageing population and rising noncommunicable disease (NCD) incidence, leads to increasing healthcare costs. Thailand's medical device and pharmaceutical manufacturers also specialise in lower-value-added product categories such as medical consumables or generic medicines, contributing to the country's continued reliance on imports. The COVID-19 outbreak taught the government a hard lesson about the dangers of import dependence, and it has implemented financial incentives to encourage companies to invest in building domestic medical devices and pharmaceutical production capacity. The government has also formed a high-level committee to review the public healthcare system, aiming to transform it into a modern and world-class system that can deal with present and emerging health challenges.



This report provides a complete and detailed analysis of the "Pharmaceuticals production" sector for Thailand. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:
  • Understand the key elements at play in the "Pharmaceuticals production" sector in Thailand
  • Crystallise the forces both driving and restraining this sector in Thailand
  • Ascertain Thailand’s position in the global sector
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in Thailand.
  • Build a clear picture of trends, output and consumption for specific sub-sectors
Thailand Pharma and Healthcare Sector Report 2025-2026 - Page 1
Buy full report USD 995.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: emisstoresupport@isimarkets.com

SEE BELOW SAMPLE PAGES FROM OUR INDUSTRY REPORTS:

ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?